Recruiting studies: Whole Brain Radiotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Phase 3 · 1 location(s) · Tata Memorial Hospital · NCT05236946 WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT06243003 Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07443397 Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05011045 Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
EARLY_Phase 1 · 1 location(s) · Emory University · NCT06328686 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · 86 location(s) · Canadian Cancer Trials Group · NCT03550391 Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Techni
Phase 2 · 2 location(s) · Medical College of Wisconsin · NCT05045950 A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · 166 location(s) · Children's Oncology Group · NCT04684368 Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
Phase 1 · 1 location(s) · Sichuan University · NCT06431685 Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · 231 location(s) · NRG Oncology · NCT04804644 SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06457906 Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Phase 3 · 3 location(s) · Sun Yat-sen University · NCT07481786 Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionat
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT04006561 NTS-WBRT in Brain Metastases
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05013892 Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Canc
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07505173 A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function De
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT02504788 Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT04899908 Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT07248228

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.